Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

NCT06826118

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

NCT06824883

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)

NCT06823960

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: AOU SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy

IRCCS-AOU di Bologna Bologna, Italy

P.O. Garibaldi-Nesima_UOC Ematologia Catania, Italy

AO di Cosenza, P.O. "Annunziata" - UOC di Ematologia Cosenza, Italy

View all 15 locations

View Trial Details

Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT06822868

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma

NCT06813573

Conditions: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations: Gustave Roussy Villejuif, France

View Trial Details

Recruiting

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma

NCT06464861

Conditions: Diffuse Large B Cell Lymphoma( DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: the Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL

NCT06530511

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Affiliated hospital of Nantong University Nantong, Jiangsu, China

Jiangsu Province Hospital Nanjing, China

View Trial Details

Recruiting

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Immunotherapy in Lymphoma

NCT06796517

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
Locations: Seoul St. Mary Hospital Seoul, South Korea

Yeoido St. Mary Hospital Seoul, South Korea

View Trial Details

Recruiting

Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

NCT06793241

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions